Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Donald Bodenner

Concepts (247)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
110
2.080
 Why?
Thyroidectomy
13
2019
59
1.920
 Why?
Parathyroidectomy
8
2018
45
1.360
 Why?
Thyroid Diseases
6
2019
25
1.310
 Why?
Parathyroid Neoplasms
5
2015
26
1.140
 Why?
Thyroid Gland
7
2017
73
1.090
 Why?
Parathyroid Hormone
8
2019
147
1.000
 Why?
Adenoma
4
2017
110
1.000
 Why?
Vitamin D Deficiency
5
2019
44
1.000
 Why?
Vitamin D
4
2015
88
0.850
 Why?
Fluorodeoxyglucose F18
6
2013
192
0.770
 Why?
Positron-Emission Tomography
7
2013
295
0.760
 Why?
Carcinoma, Papillary
4
2017
48
0.740
 Why?
Radiopharmaceuticals
7
2015
209
0.740
 Why?
Ambulatory Surgical Procedures
4
2014
46
0.730
 Why?
Hyperparathyroidism, Primary
4
2018
35
0.690
 Why?
Hyperparathyroidism
2
2015
31
0.620
 Why?
Iodine Radioisotopes
3
2015
35
0.590
 Why?
Megestrol Acetate
2
2007
17
0.560
 Why?
Parathyroid Diseases
2
2016
5
0.550
 Why?
Bone Density Conservation Agents
2
2007
77
0.530
 Why?
Nursing Homes
2
2007
114
0.530
 Why?
Incidental Findings
3
2013
39
0.510
 Why?
Proton Pump Inhibitors
1
2015
84
0.490
 Why?
Diphosphonates
1
2015
90
0.490
 Why?
Academic Medical Centers
2
2012
144
0.480
 Why?
Thyroglobulin
2
2013
7
0.480
 Why?
Aged
19
2017
9310
0.460
 Why?
Parathyroid Glands
5
2018
20
0.450
 Why?
Carcinoma, Medullary
2
2010
12
0.450
 Why?
Middle Aged
25
2017
12069
0.450
 Why?
Hypothyroidism
2
2011
54
0.410
 Why?
Male
31
2019
25241
0.410
 Why?
Retrospective Studies
14
2019
6108
0.400
 Why?
Postoperative Complications
5
2018
984
0.390
 Why?
Calcitonin
2
2010
30
0.390
 Why?
Carcinoma
2
2012
138
0.360
 Why?
Humans
44
2019
49974
0.360
 Why?
Algorithms
1
2013
615
0.350
 Why?
Thyroid Nodule
3
2017
31
0.350
 Why?
Female
29
2019
26472
0.330
 Why?
Weight Loss
2
2009
237
0.330
 Why?
Appetite Stimulants
1
2007
5
0.300
 Why?
Aged, 80 and over
9
2017
3129
0.290
 Why?
Cachexia
1
2007
25
0.290
 Why?
Teriparatide
1
2007
11
0.290
 Why?
Four-Dimensional Computed Tomography
2
2017
27
0.270
 Why?
Hypocalcemia
2
2016
8
0.270
 Why?
Pituitary Hormones, Anterior
1
2005
4
0.260
 Why?
Calcium
3
2018
396
0.260
 Why?
Phenylurea Compounds
2
2015
15
0.260
 Why?
Hormones
1
2005
55
0.260
 Why?
Quinolines
2
2015
40
0.250
 Why?
Osteoporosis
1
2007
146
0.250
 Why?
Transcriptional Activation
1
2005
121
0.250
 Why?
Pituitary Gland
1
2005
86
0.250
 Why?
Receptors, Estrogen
1
2005
130
0.250
 Why?
Interleukin-6
1
2005
264
0.230
 Why?
NF-kappa B
1
2005
314
0.230
 Why?
Protein Kinase Inhibitors
2
2015
204
0.220
 Why?
Biopsy, Fine-Needle
5
2011
103
0.220
 Why?
Illinois
2
2013
11
0.210
 Why?
Treatment Outcome
8
2015
5141
0.210
 Why?
Adult
13
2017
13236
0.200
 Why?
Gene Expression Regulation
1
2005
976
0.180
 Why?
Aging
1
2005
687
0.180
 Why?
Young Adult
7
2015
3958
0.180
 Why?
Follow-Up Studies
3
2013
2182
0.170
 Why?
Hyperparathyroidism, Secondary
1
2019
4
0.170
 Why?
Postoperative Period
3
2015
170
0.160
 Why?
Preoperative Care
2
2018
164
0.150
 Why?
Vitamins
2
2018
64
0.150
 Why?
Patient Discharge
3
2016
320
0.150
 Why?
Intraoperative Complications
1
2019
112
0.150
 Why?
Insulin Resistance
2
2009
264
0.140
 Why?
United States
5
2015
4860
0.140
 Why?
Prospective Studies
2
2013
2364
0.140
 Why?
Antineoplastic Agents
2
2015
1171
0.140
 Why?
Predictive Value of Tests
3
2015
903
0.140
 Why?
Incidence
2
2011
1003
0.130
 Why?
Reoperation
1
2018
454
0.130
 Why?
Adolescent
5
2015
6356
0.130
 Why?
Hypoparathyroidism
1
2015
5
0.130
 Why?
Carcinoma, Neuroendocrine
1
2015
24
0.130
 Why?
Creatinine
1
2015
139
0.130
 Why?
Tomography, Emission-Computed, Single-Photon
1
2015
52
0.130
 Why?
Costs and Cost Analysis
2
2014
95
0.130
 Why?
Disease Progression
3
2015
825
0.130
 Why?
Lymph Nodes
1
2017
260
0.120
 Why?
Molecular Targeted Therapy
1
2015
119
0.120
 Why?
Ambulatory Care
1
2016
222
0.120
 Why?
Diagnosis, Differential
6
2018
1037
0.120
 Why?
Neoplasm Metastasis
2
2015
231
0.120
 Why?
Hospitals, University
1
2014
77
0.120
 Why?
Child, Preschool
2
2013
3871
0.120
 Why?
Sensitivity and Specificity
2
2013
861
0.110
 Why?
Exercise
2
2009
495
0.110
 Why?
Liver
2
2009
1115
0.110
 Why?
Drug Administration Schedule
1
2013
376
0.110
 Why?
Hospitals, Teaching
1
2013
53
0.110
 Why?
Technetium
1
2012
9
0.110
 Why?
Preoperative Period
1
2012
46
0.110
 Why?
Administration, Oral
1
2013
426
0.110
 Why?
Radionuclide Imaging
1
2012
116
0.100
 Why?
Outpatients
1
2013
113
0.100
 Why?
Patient Compliance
1
2013
230
0.100
 Why?
Clinical Competence
2
2018
393
0.100
 Why?
Hospital Charges
1
2012
43
0.100
 Why?
Struma Ovarii
1
2012
5
0.100
 Why?
Tumor Burden
1
2012
132
0.100
 Why?
Cost Savings
1
2012
58
0.100
 Why?
Prognosis
3
2015
1942
0.100
 Why?
Child
3
2013
6847
0.100
 Why?
Ovariectomy
1
2012
119
0.100
 Why?
Immunohistochemistry
2
2012
973
0.090
 Why?
Chromogranin A
1
2010
5
0.090
 Why?
Obesity
2
2009
1113
0.090
 Why?
Radiation Monitoring
1
2010
7
0.090
 Why?
Checklist
1
2010
29
0.090
 Why?
Dose-Response Relationship, Drug
1
2013
1376
0.090
 Why?
Inpatients
1
2011
190
0.090
 Why?
Radiosurgery
1
2011
118
0.090
 Why?
Fatal Outcome
1
2010
195
0.090
 Why?
Databases, Factual
1
2013
658
0.090
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.090
 Why?
Caloric Restriction
1
2009
36
0.090
 Why?
Ultrasonography
4
2015
436
0.080
 Why?
Intra-Abdominal Fat
1
2009
20
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
 Why?
General Surgery
1
2010
105
0.080
 Why?
Occupational Exposure
1
2010
122
0.080
 Why?
Receptors, Thyrotropin
1
2007
7
0.080
 Why?
Blastomycosis
1
2008
62
0.080
 Why?
Symporters
1
2007
17
0.080
 Why?
Adenoma, Oxyphilic
1
2007
11
0.080
 Why?
Severity of Illness Index
1
2011
945
0.070
 Why?
Whole Body Imaging
1
2007
22
0.070
 Why?
Time Factors
3
2015
2903
0.070
 Why?
Anorexia
1
2007
7
0.070
 Why?
Ovarian Neoplasms
1
2012
447
0.070
 Why?
Adiposity
1
2009
127
0.070
 Why?
DNA, Neoplasm
1
2007
147
0.070
 Why?
Calcifediol
1
2006
9
0.070
 Why?
Calcium Carbonate
1
2006
11
0.070
 Why?
Medical Audit
1
2006
21
0.070
 Why?
Practice Management, Medical
1
2006
12
0.070
 Why?
Drug Utilization Review
1
2006
23
0.070
 Why?
Promoter Regions, Genetic
2
2007
475
0.070
 Why?
Drug Monitoring
1
2006
77
0.070
 Why?
Head
1
2006
73
0.070
 Why?
Cross-Sectional Studies
2
2014
1557
0.070
 Why?
Body Mass Index
2
2009
652
0.070
 Why?
Geriatrics
1
2006
46
0.070
 Why?
Gene Expression Regulation, Neoplastic
1
2010
828
0.070
 Why?
Otolaryngology
1
2006
55
0.070
 Why?
Neck
1
2006
99
0.070
 Why?
Proportional Hazards Models
1
2007
402
0.070
 Why?
Progesterone Congeners
1
2005
5
0.070
 Why?
Body Fat Distribution
1
2005
9
0.070
 Why?
Freezing
1
2005
16
0.070
 Why?
Faculty, Medical
1
2006
89
0.070
 Why?
Arkansas
2
2014
1977
0.060
 Why?
Fractures, Bone
1
2006
107
0.060
 Why?
Serum
1
2005
32
0.060
 Why?
Survival Analysis
1
2007
653
0.060
 Why?
DNA Primers
1
2005
207
0.060
 Why?
Reproducibility of Results
3
2017
1193
0.060
 Why?
HeLa Cells
1
2005
250
0.060
 Why?
Internship and Residency
1
2010
443
0.060
 Why?
Base Sequence
1
2005
643
0.060
 Why?
Nuclear Proteins
1
2005
242
0.060
 Why?
Infant
1
2012
3567
0.060
 Why?
Protein Binding
1
2005
660
0.060
 Why?
ROC Curve
2
2015
232
0.050
 Why?
Patient Selection
2
2018
253
0.050
 Why?
Intraoperative Period
2
2015
45
0.050
 Why?
Randomized Controlled Trials as Topic
1
2005
549
0.050
 Why?
Tomography, X-Ray Computed
3
2012
1159
0.050
 Why?
Thalidomide
1
2002
377
0.040
 Why?
Glucagon
2
2009
22
0.040
 Why?
Cohort Studies
2
2015
1422
0.040
 Why?
Monitoring, Intraoperative
1
2019
54
0.040
 Why?
Cholecalciferol
1
2018
23
0.040
 Why?
Hospitals, High-Volume
1
2018
25
0.040
 Why?
Medical History Taking
1
2018
47
0.040
 Why?
Risk Factors
1
2006
3613
0.040
 Why?
Pilot Projects
2
2010
699
0.040
 Why?
Lymphatic System
1
2017
14
0.040
 Why?
Methylene Blue
1
2017
10
0.040
 Why?
Societies, Medical
1
2018
175
0.040
 Why?
Animals, Genetically Modified
1
2017
49
0.040
 Why?
Coloring Agents
1
2017
69
0.040
 Why?
Mice, Inbred Strains
1
2017
161
0.040
 Why?
Insulin
2
2009
457
0.040
 Why?
Proto-Oncogene Proteins B-raf
1
2017
79
0.040
 Why?
Recurrence
1
2018
652
0.030
 Why?
Lymphatic Metastasis
1
2017
224
0.030
 Why?
Bone Density
1
2018
379
0.030
 Why?
Technetium Tc 99m Sestamibi
1
2015
18
0.030
 Why?
Retreatment
1
2015
57
0.030
 Why?
Brachial Plexus
1
2015
14
0.030
 Why?
Endocrinology
1
2015
10
0.030
 Why?
Axilla
1
2015
89
0.030
 Why?
Hematoma
1
2015
64
0.030
 Why?
Transplantation, Autologous
1
2015
466
0.030
 Why?
Neoplasm Staging
1
2015
740
0.030
 Why?
Hernia, Abdominal
1
2012
4
0.030
 Why?
Activating Transcription Factor 1
1
2012
18
0.030
 Why?
Delayed Diagnosis
1
2012
23
0.020
 Why?
Mutation
1
2017
1294
0.020
 Why?
Ribs
1
2010
15
0.020
 Why?
Thoracotomy
1
2010
34
0.020
 Why?
Mediastinal Neoplasms
1
2010
19
0.020
 Why?
Neck Dissection
1
2010
31
0.020
 Why?
Hypercalcemia
1
2010
33
0.020
 Why?
Feasibility Studies
1
2011
375
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2009
67
0.020
 Why?
Hospitalization
1
2014
652
0.020
 Why?
Octreotide
1
2009
9
0.020
 Why?
Prevalence
1
2012
944
0.020
 Why?
Glucose Tolerance Test
1
2009
57
0.020
 Why?
Adiponectin
1
2009
64
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
244
0.020
 Why?
Absorptiometry, Photon
1
2009
154
0.020
 Why?
Postmenopause
1
2009
100
0.020
 Why?
Eye
1
2008
31
0.020
 Why?
Bone Neoplasms
1
2010
179
0.020
 Why?
Iodine
1
2007
10
0.020
 Why?
Methylation
1
2007
122
0.020
 Why?
Neoplasm Recurrence, Local
1
2011
614
0.020
 Why?
Body Weight
1
2009
513
0.020
 Why?
Multiple Myeloma
1
2002
2929
0.020
 Why?
Overweight
1
2009
219
0.020
 Why?
Current Procedural Terminology
1
2006
7
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Office Visits
1
2006
41
0.020
 Why?
Mice
1
2017
5739
0.020
 Why?
Polymerase Chain Reaction
1
2007
453
0.020
 Why?
Genetic Predisposition to Disease
1
2009
510
0.020
 Why?
Blood Glucose
1
2009
439
0.020
 Why?
Risk Assessment
1
2010
1259
0.020
 Why?
Lung
1
2008
486
0.010
 Why?
Muscle, Skeletal
1
2009
750
0.010
 Why?
Thyroid Function Tests
1
2002
24
0.010
 Why?
Thyrotropin
1
2002
47
0.010
 Why?
Animals
1
2017
13187
0.010
 Why?
Clinical Trials as Topic
1
2002
461
0.010
 Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (247) concept(s)
_
Co-Authors Expand Description
See all (19) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department